“Efficacy of Apremilast on Quality-of-Life Measures in Patients with Moderate Plaque Psoriasis (UNVEIL Phase IV Study)” (2017) SKIN The Journal of Cutaneous Medicine, 1(3.1), p. s13. doi:10.25251/skin.1.supp.12.